Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I

American Journal of Clinical Pathology

Volumn 130, Issue 1, 2008, Pages 132-135

  Bock, Jay L ^a,b   Singer, Adam J ^b   Thode Jr , Henry C ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Acute coronary syndrome; Immunoassay; Point of care testing; Troponin I

Indexed keywords

CARDIAC TROPONIN I; CONTRACTILE PROTEIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CENTRAL LABORATORY METHOD; CHILD; EMERGENCY WARD; FEMALE; HUMAN; INFANT; MALE; PATIENT CODING; PATIENT SELECTION; POINT OF CARE TESTING; PRIORITY JOURNAL; SCREENING TEST;

ACUTE CORONARY SYNDROME; EMERGENCY SERVICE, HOSPITAL; HEMATOLOGIC TESTS; HUMANS; LABORATORIES, HOSPITAL; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; TROPONIN I;

EID: 48249118819     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/NVXH8DL5HWFDNB74     Document Type: Article

References (15)

1. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
2. Katrukha AG, Bereznikova AV, Esakova TV, et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem. 1997;43:1379-1385.
3. Katrukha A, Bereznikova A, Filatov V, et al. Biochemical factors influencing measurement of cardiac troponin I in serum. Clin Chem Lab Med. 1999;37:1091-1095.
4. Wu AH, Feng YJ, Moore R, et al, for the American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem. 1998;44:1198-1208.
5. Fitzmaurice TF, Brown C, Rifai N, et al. False increase of cardiac troponin I with heterophilic antibodies. Clin Chem. 1998;44:2212-2214.
6. Kazmierczak SC, Sekhon H, Richards C. False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference. Int J Cardiol. 2005;101:27-31.
7. Schulz O, Paul-Walter C, Lehmann M, et al. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. Am J Cardiol. 2007;100:764-769.
8. Waxman DA, Hecht S, Schappert J, et al. A model for troponin I as a quantitative predictor of in-hospital mortality. J Am Coll Cardiol. 2006;48:1755-1762.
9. Hickman PE, Badrick T, Wilson SR, et al. Reporting of cardiac troponin: problems with the 99th population percentile [letter]. Clin Chim Acta. 2007;381:182-183.
10. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol. 2007;128:282-286.
11. Jossi S, Gordon SL, Legge MA, et al. All troponins are not created equal. Intern Med J. 2006;36:325-327.
12. Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem. 2007;53:547-551.
13. Cramer GE, Kievit PC, Brouwer MA, et al. Lack of concordance between a rapid bedside and conventional laboratory method of cardiac troponin testing: impact on risk stratification of patients suspected of acute coronary syndrome. Clin Chim Acta. 2007;381:164-166.
14. Apple FS, Murakami MM, Christenson RH, et al. Analytical performance of the i-STAT cardiac troponin I assay. Clin Chim Acta. 2004;345:123-127.
15. Foohey L, Neighbor S, Buchmelter T. Troponin Clinical Applications. Tarrytown, NY: Bayer Healthcare; 2006.